159 related articles for article (PubMed ID: 33907830)
1. Schisandrin B inhibits epithelial‑mesenchymal transition and stemness of large‑cell lung cancer cells and tumorigenesis in xenografts via inhibiting the NF‑κB and p38 MAPK signaling pathways.
Li S; Wang H; Ma R; Wang L
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907830
[TBL] [Abstract][Full Text] [Related]
2. Schisandrin B suppresses TGFβ1 signaling by inhibiting Smad2/3 and MAPK pathways.
Park EJ; Chun JN; Kim SH; Kim CY; Lee HJ; Kim HK; Park JK; Lee SW; So I; Jeon JH
Biochem Pharmacol; 2012 Feb; 83(3):378-84. PubMed ID: 22100726
[TBL] [Abstract][Full Text] [Related]
3. Schisandrin B inhibits TGF-β1-induced epithelial-mesenchymal transition in human A549 cells through epigenetic silencing of ZEB1.
Zhuang W; Li Z; Dong X; Zhao N; Liu Y; Wang C; Chen J
Exp Lung Res; 2019; 45(5-6):157-166. PubMed ID: 31268360
[No Abstract] [Full Text] [Related]
4. Protective effects of Schisandrin B on cigarette smoke-induced airway injury in mice through Nrf2 pathway.
Jia R; Zhang H; Yang Z; Zhao H; Liu F; Wang H; Miao M; Wang Q; Liu Y
Int Immunopharmacol; 2017 Dec; 53():11-16. PubMed ID: 29031142
[TBL] [Abstract][Full Text] [Related]
5. Schisandrin B attenuates cancer invasion and metastasis via inhibiting epithelial-mesenchymal transition.
Liu Z; Zhang B; Liu K; Ding Z; Hu X
PLoS One; 2012; 7(7):e40480. PubMed ID: 22848381
[TBL] [Abstract][Full Text] [Related]
6. Schisandrin B Improves the Renal Function of IgA Nephropathy Rats Through Inhibition of the NF-κB Signalling Pathway.
Qin JH; Lin JR; Ding WF; Wu WH
Inflammation; 2019 Jun; 42(3):884-894. PubMed ID: 30519926
[TBL] [Abstract][Full Text] [Related]
7. Schizandrin B inhibits the cis‑DDP‑induced apoptosis of HK‑2 cells by activating ERK/NF‑κB signaling to regulate the expression of survivin.
Liu Q; Song J; Li H; Dong L; Dai S
Int J Mol Med; 2018 Apr; 41(4):2108-2116. PubMed ID: 29393335
[TBL] [Abstract][Full Text] [Related]
8. Schisandrin B inhibits LPS-induced inflammatory response in human umbilical vein endothelial cells by activating Nrf2.
Lin Q; Qin X; Shi M; Qin Z; Meng Y; Qin Z; Guo S
Int Immunopharmacol; 2017 Aug; 49():142-147. PubMed ID: 28577438
[TBL] [Abstract][Full Text] [Related]
9. Arenobufagin, isolated from toad venom, inhibited epithelial-to-mesenchymal transition and suppressed migration and invasion of lung cancer cells via targeting IKKβ/NFκB signal cascade.
Zhao J; Zhang Q; Zou G; Gao G; Yue Q
J Ethnopharmacol; 2020 Mar; 250():112492. PubMed ID: 31866511
[TBL] [Abstract][Full Text] [Related]
10. Comparative Effects of Schisandrin A, B, and C on Acne-Related Inflammation.
Guo M; An F; Wei X; Hong M; Lu Y
Inflammation; 2017 Dec; 40(6):2163-2172. PubMed ID: 28875271
[TBL] [Abstract][Full Text] [Related]
11. [Effects of schisandrin B on reversing multidrug resistance in human breast cancer cells transfected with mdr1 gene].
Li L; Wang T; Xu ZL; Yu Y; Chen W; Chen F
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(23):1633-7. PubMed ID: 16185533
[TBL] [Abstract][Full Text] [Related]
12. Schisandrin B suppresses TGFβ1-induced stress fiber formation by inhibiting myosin light chain phosphorylation.
Chun JN; Kim SY; Park EJ; Kwon EJ; Bae DJ; Kim IS; Kim HK; Park JK; Lee SW; Park HH; So I; Jeon JH
J Ethnopharmacol; 2014 Mar; 152(2):364-71. PubMed ID: 24486209
[TBL] [Abstract][Full Text] [Related]
13. Schisandrin B prevents ulcerative colitis and colitis-associated-cancer by activating focal adhesion kinase and influence on gut microbiota in an in vivo and in vitro model.
Li J; Lu Y; Wang D; Quan F; Chen X; Sun R; Zhao S; Yang Z; Tao W; Ding D; Gao X; Cao Q; Zhao D; Qi R; Chen C; He L; Hu K; Chen Z; Yang Y; Luo Y
Eur J Pharmacol; 2019 Jul; 854():9-21. PubMed ID: 30951716
[TBL] [Abstract][Full Text] [Related]
14. Suppression of P2X7/NF-κB pathways by Schisandrin B contributes to attenuation of lipopolysaccharide-induced inflammatory responses in acute lung injury.
Cai Z; Liu J; Bian H; Cai J; Zhu G
Arch Pharm Res; 2016 Apr; 39(4):499-507. PubMed ID: 26832323
[TBL] [Abstract][Full Text] [Related]
15. Schisandrin B alleviates diabetic nephropathy through suppressing excessive inflammation and oxidative stress.
Mou Z; Feng Z; Xu Z; Zhuang F; Zheng X; Li X; Qian J; Liang G
Biochem Biophys Res Commun; 2019 Jan; 508(1):243-249. PubMed ID: 30477745
[TBL] [Abstract][Full Text] [Related]
16. Sedative and hypnotic effects of Schisandrin B through increasing GABA/Glu ratio and upregulating the expression of GABA
Li N; Liu J; Wang M; Yu Z; Zhu K; Gao J; Wang C; Sun J; Chen J; Li H
Biomed Pharmacother; 2018 Jul; 103():509-516. PubMed ID: 29677536
[TBL] [Abstract][Full Text] [Related]
17. Schisandrin A inhibits triple negative breast cancer cells by regulating Wnt/ER stress signaling pathway.
Xu X; Rajamanicham V; Xu S; Liu Z; Yan T; Liang G; Guo G; Zhou H; Wang Y
Biomed Pharmacother; 2019 Jul; 115():108922. PubMed ID: 31048190
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of cyclosporine A induced nephrotoxicity by schisandrin B through suppression of oxidative stress, apoptosis and autophagy.
Lai Q; Luo Z; Wu C; Lai S; Wei H; Li T; Wang Q; Yu Y
Int Immunopharmacol; 2017 Nov; 52():15-23. PubMed ID: 28846887
[TBL] [Abstract][Full Text] [Related]
19. Tobacco smoke induced hepatic cancer stem cell-like properties through IL-33/p38 pathway.
Xie C; Zhu J; Wang X; Chen J; Geng S; Wu J; Zhong C; Li X
J Exp Clin Cancer Res; 2019 Jan; 38(1):39. PubMed ID: 30691509
[TBL] [Abstract][Full Text] [Related]
20. Lipidomic-based investigation into the regulatory effect of Schisandrin B on palmitic acid level in non-alcoholic steatotic livers.
Kwan HY; Niu X; Dai W; Tong T; Chao X; Su T; Chan CL; Lee KC; Fu X; Yi H; Yu H; Li T; Tse AK; Fong WF; Pan SY; Lu A; Yu ZL
Sci Rep; 2015 Mar; 5():9114. PubMed ID: 25766252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
